Phibro Animal Health grants 2,478 RSUs to SVP

Weinstein Judith reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Weinstein Judith reported acquisition or exercise transactions in this Form 4 filing.

Phibro Animal Health Corp reported an equity compensation award to senior vice president and general counsel Judith Weinstein. She received 2,478 restricted stock units, each representing one share of Class A Common Stock, increasing her direct holdings to 5,453 shares. The RSUs vest in substantially equal installments over three years starting on August 1, 2026, conditioned on continued employment through each vesting date.

Insider Trade Summary

Grant/Award: 2,478 shares

Grant/Award 1 txn

Insider Weinstein Judith

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1, F2	2,478	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 5,453 shares (Direct)

Footnotes (2)

1. F1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. F2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

Key Figures

RSUs granted: 2,478 shares Shares held after transaction: 5,453 shares RSU vesting period: 3 installments +1 more

4 metrics

RSUs granted 2,478 shares Restricted stock units representing Class A Common Stock awarded on 2026-08-06

Shares held after transaction 5,453 shares Direct Class A Common Stock holdings following RSU grant

RSU vesting period 3 installments Vesting in substantially equal installments on first three anniversaries of August 1, 2026

Grant price per share $0.0000 Reported transaction price per share for the RSU award

Key Terms

restricted stock units, Class A Common Stock, vest, contingent right

4 terms

restricted stock units financial

"The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"each of which represents a contingent right to receive one share of Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vest financial

"The RSUs vest in substantially equal installments on each of the first three anniversaries"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

contingent right financial

"RSUs, each of which represents a contingent right to receive one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did Judith Weinstein receive from PAHC in this Form 4?

Judith Weinstein received 2,478 restricted stock units (RSUs), each representing a contingent right to one share of Class A Common Stock. This award is reported as a grant or other acquisition of equity-based compensation.

How many PAHC shares does Judith Weinstein hold after this reported transaction?

Following the RSU grant, Judith Weinstein is reported as holding 5,453 shares of Phibro Animal Health Class A Common Stock directly. This figure includes the impact of the 2,478 newly awarded RSUs reported in the filing.

How do the PAHC RSUs granted to Judith Weinstein vest?

The 2,478 RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026. Vesting is subject to her continued employment with Phibro Animal Health through each applicable vesting date.

Does Phibro Animal Health (PAHC) report any sale of shares in this Form 4?

No sales are reported; the filing shows a grant of 2,478 RSUs classified as an acquisition. The transaction code "A" indicates a grant, award, or other acquisition rather than an open-market purchase or sale.

Is the RSU grant to Judith Weinstein tied to a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and there is no footnote stating that this RSU grant was made under a Rule 10b5-1 trading plan or other pre-arranged trading arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 04:17 PM Accepted by SEC EDGAR 08/10/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weinstein Judith

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	08/06/2026		A		2,478(2)	A	$0	5,453	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.

2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

Remarks:

Senior Vice President, General Counsel and Corporate Secretary.

	/s/ Judith Weinstein	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)